Latest News

Moderna’s Bundibugyo ebolavirus vaccine candidate enters first human trial, backed by CEPI

The trial launch marks a major step forward in efforts to respond to the deadly Ebola outbreak in the Democratic Republic of the Congo (DRC).

Discover the latest CEPI news

Keep up-to-date on the latest announcements and updates from CEPI and our global partners.

Smaller COVID-19 vaccine booster doses match full-dose protection for up to two years

Reducing the size of COVID-19 vaccine boosters doses still produces strong immune responses that remain over time, a new multi-year research project run across several countries has found.